Piscataway, New Jersey
Kashiv BioSciences’ 50,000 sq. ft. R&D facility has capabilities for mammalian cell line development, advanced analytical characterization, bioassay development, and small-scale manufacturing of complex proteins and monoclonal antibodies.
Analytical Characterization Lab
Cell Line Process Development
Biosimilar R&D Facility
Chicago, Illinois
Kashiv BioSciences’ 100,000 sq.ft. R&D and manufacturing facility has capabilities for development and manufacturing of commercial-scale microbial cell lines, drug substance, and a fill and finish line for prefilled syringes and vials. It is an FDA-registered site and complies fully with Local, State, and Federal Agencies, OSHA, EPA, and cGMP Standards.
Upstream Production Suite
Injectable Fill and Finish Line
Biosimilar R&D and Injectable Manufacturing Facility
Ahmedabad, Gujarat, India
Kashiv BioSciences Private Limited's 125,000 sq.ft. R&D facility contains state-of-the-art analytical labs for characterization, stability, bioassay development, process development, and small scale manufacturing of complex proteins for biosimilars.
India office and R&D facility
Biosimilars and complex product development
Analytical labs equipped with the latest technology
Pipan, Gujarat, India
Kashiv BioSciences is constructing a world-class biologics manufacturing facility with industry-leading capacity to support the commercial launches of Kashiv's advanced biosimilars pipeline. The site is expected to become operational in 2026.
